NCT06195163View on ClinicalTrials.gov

TRAP Study: Testosterone for Androgen Receptor Polymorphism

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Fertility Disorders
Interventions
DRUG

Transdermal Gel in Sachet Dosage Form

Transdermal testosterone gel application prior to ovarian stimulation in the study group.

DRUG

No pretreatment

No pretreatment prior to the ovarian stimulation in the control group.

Trial Locations (1)

03016

Instituto Bernabeu, Alicante

Sponsors

Lead Sponsor

Instituto Bernabeu
All Listed Sponsors
lead

Instituto Bernabeu

OTHER